VIRALEZE™ Barrier Nasal Spray

VIRALEZE™ provides a protective moisture barrier in the nose where cold/respiratory viruses first attach and start to multiply.

Contains astodrimer sodium, proven in laboratory studies to physically trap and block cold/respiratory viruses.

Always read the label and follow the instructions for use. This medical device is a regulated health product which bears, under this regulation, the CE marking. Do not use if you have a history of sensitivity to any ingredient in the formulation. For use in adults and children over the age of 12 years. See a doctor if you are pregnant or breastfeeding. For information on how to use, and for a list of warnings and precautions, click here.

Targets the area of the nose where cold/respiratory viruses first attach and start to multiply

Forms a physical moisture barrier between cold/respiratory viruses and the nasal mucosa

The physical barrier provided by VIRALEZE™ traps and blocks cold/respiratory viruses

Helps protect against nasal drying and damage

Acts locally and is not absorbed into the bloodstream

What is VIRALEZE™ Barrier Nasal Spray?

VIRALEZE™ is a nasal spray that provides a physical moisture barrier between cold/respiratory viruses and the nasal mucosa. The formulation contains astodrimer sodium, which has been proven in laboratory studies to physically trap and block cold/respiratory viruses^, helping to prevent their adhesion to the nasal mucous membrane.

VIRALEZE™ is intended to be used in situations where individuals may be exposed to cold/respiratory viruses, and where nasal passages may become dry and irritated, such as dry climates, indoor heated/air-conditioned environments, hospitals, aged care, public transport and during air travel.

This medical device is a regulated health product which bears, under this regulation, the CE marking.

^Gallay et al., Top Antiv Med, 2022, 30(1s), 478
Paull JRA et al., Antivir Res, 2021, 191, 105089
Paull JRA et al., Viruses, 2021, 13, 1656
Testing of astodrimer sodium was conducted at The Scripps Research Institute, USA and 360biolabs, Australia.

How does VIRALEZE™ work?

The nasal cavity is the primary site where cold/respiratory viruses become established before a cold/respiratory infection develops.

Mucus is naturally produced in the nose and its role is to trap foreign particles, including viruses, and reduce the chance of them infecting cells in the nasal cavity and entering the lungs. The mucoadhesive formula of VIRALEZE™ provides an additional moisture barrier in your nose that aims to help keep the nasal mucosa hydrated, for protection against mucosal drying and damage, thereby supporting your body’s natural defenses against viruses.

VIRALEZE™ contains astodrimer sodium, which has been proven in laboratory studies to physically trap and block cold/respiratory viruses^. The blocked and trapped viruses are then eliminated naturally with the nasal mucus.

^Gallay et al., Top Antiv Med, 2022, 30(1s), 478 Paull JRA et al., Antivir Res, 2021, 191, 105089 Paull JRA et al., Viruses, 2021, 13, 1656 Testing of astodrimer sodium was conducted at The Scripps Research Institute, USA and 360biolabs, Australia.

VIRALEZE™ developed in Australia by Starpharma

Get your VIRALEZE™ today.